A World-spanning consortium

Partners

MultipleMS group photo taken at the kickoff meeting in Paris on the 24^thof January 2017.

MultipleMS has 22partners originating from 15 countries, with the main hub at the Karolinska Institutet, Stockholm, Sweden. The consortium will grow by addition of new centres of excellence during the project phase.

1. Department of Clinical Neuroscience, Centre for Molecular Medicine, Karolinska Institutet, Stockholm SE
2. Mabtech AB (Swedish biotech company), Stockholm SE
3. YouHealth AB (Swedish bioinformatics company), Stockholm SE
4. Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki FI
5. Biocomputing Platforms Oy, (Finnish bioinformatics company), Espoo FI
6. Department of Neurology, University of Oslo, Oslo NO
7. Department of Neurology, Danish Multiple Sclerosis Center, Rigshospitalet, Copenhagen DK
8. TUM School of Medicine, Technical University of Munich, Munich DE
9. Department of Neurosciences, KU Leuven, Leuven BE
10. Department of Cancer Biology, University College London, London UK
11. MedImmune (AstraZeneca), Cambridge UK
12. Department of Clinical Neurosciences, University of Cambridge, Cambridge UK
13. European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton UK
14. NEURIX (Swiss biotech company), Geneva CH
15. Institut d’Investigacions Biomediques August Pi Sunye (IDIBAPS), Barcelona ES
16. Laboratory of Human Genetics of Neurological Disoders and Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, Scientific Institute San Raffaele, Milan IT
17. Department of Health Sciences, Università del Piemonte Orientale, Novara IT
18. Department of Neurology, University of California and San Francisco, San Francisco USA
19. ALTIUS Institute for Biomedical Sciences, Seattle USA
20. Department of Mathematics, KTH Royal Institute of Technology, Stockholm SE
21. Sanofi-Aventis Research and Development, Chilly-Mazarin FR
22. IRCCS Policlinico San Donato, IT

Consulting through:

   23. PricewaterhouseCoopers, Amsterdam, Netherlands

MultipleMS is funded by the European Union under the Horizon 2020 programme, grant agreement 733161. The contents of this website are the sole responsibility of the MultipleMS project and do not necessarily reflect the views of the European Union.